Jianmin Pharmaceutical Group Co., Ltd. (600976)
Market Closed
10 Aug, 06:57
SSE SSE Primary ¥
29. 56
-0.59
-1.9569%
¥
6.2B Market Cap
- P/E Ratio
4.8% Div Yield
3.8M Volume
- Eps
¥ 30.15
Previous Close Want to track 600976 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
600976 closed yesterday lower at ¥29.56, a decrease of -1.9569% from Friday's close, completing a monthly increase of 18.5245% or ¥4.62. Over the past 12 months, 600976 stock lost -12.1284%.
600976 pays dividends to its shareholders, with the most recent payment made on Apr 28, 2026. The next estimated payment will be in In 8 months on Apr 28, 2027 for a total of ¥0.9.
The last earnings report, released on Apr 19, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Jianmin Pharmaceutical Group Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jul 12, 2006.
The company's stock is traded on one exchange.
600976 Chart
People also search for
Jianmin Pharmaceutical Group Co., Ltd. (600976) FAQ
What is the stock price today?
The current price is ¥29.56.
On which exchange is it traded?
Jianmin Pharmaceutical Group Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 600976.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 4.8%.
What is its market cap?
As of today, the market cap is 6.2B.
Has Jianmin Pharmaceutical Group Co., Ltd. ever had a stock split?
Jianmin Pharmaceutical Group Co., Ltd. had 1 splits and the recent split was on Jul 12, 2006.
Jianmin Pharmaceutical Group Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jun Wang CEO | SSE Exchange | CNE000001HB7 ISIN |
| CN Country | 2,497 Employees | 28 Apr 2026 Last Dividend | 12 Jul 2006 Last Split | 2 Apr 2004 IPO Date |
Overview
Jianmin Pharmaceutical Group Co.,Ltd. is a prominent entity in China's pharmaceutical industry, dedicated to the manufacture and sale of a wide array of medicines. Since its inception in 1993, the company has made significant strides in the healthcare sector, establishing itself as a trusted source of pharmaceutical products. Headquartered in Wuhan, China, Jianmin Pharmaceutical Group has carved a niche for itself by offering high-quality medicines and pediatric drugs under the renowned brand names Jianmin, Longmu, and Yekaitai. Apart from its strong portfolio of products, the company is also recognized for its commitment to public health through the provision of consultation services, thereby reinforcing its role as a key player in the pharmaceutical landscape of China.
Products and Services
- Medicines - Jianmin Pharmaceutical Group offers a comprehensive range of medicines designed to cater to various health conditions. With a focus on quality and efficacy, these medicines are developed to meet the highest standards of healthcare.
- Pediatric Drugs - The company specializes in pediatric drugs under the brand names Jianmin, Longmu, and Yekaitai. These products are tailored to address the unique healthcare needs of children, ensuring their well-being and healthy development.
- OTC Products - Over-the-counter (OTC) products are also a significant part of Jianmin Pharmaceutical Group's portfolio. These accessible medical solutions are aimed at providing relief and treatment for common ailments without the need for a prescription.
- Medical and General Health Products - In addition to medicines and OTC products, the company offers a variety of medical and general health products. These include items that contribute to the maintenance of overall health and well-being, supporting individuals in leading healthier lives.
- Consultation Service - Recognizing the importance of informed healthcare decisions, Jianmin Pharmaceutical Group provides consultation services. This initiative enables individuals to seek professional advice regarding their health concerns, ensuring they receive the appropriate care and treatment.
Contact Information
Address: No. 484 Yingwu Avenue, Wuhan, China, 430052
Phone: 86 27 8452 3350
Website: https://www.whjm.com
